In millions except for per-share data %% %%
%% 4th Qtr. Dec. 31 1997 1996
Revenues 174 196
Net income (loss) a15.1 c49.2
Per share (diluted) 0.45 1.55
Year 1997 1996
Revenues 726 709
Net income (loss) a,b16.7 c55.2
Per share (diluted) 0.51 1.74
%% Dexion results included November 1997.
a–Net income for the 1997 fourth quarter and year include a pretax gain
of $35.6 million and tax expense of $10.4 million from the sale of
Dexion, a charge of $10.5 million for environmental expenses, and
a pretax charge of $900,000 related to bank debt.
b–Net income for the year also includes an after-tax charge of $1.5
million for the repurchase of senior notes.
c–Net income in 1996 fourth quarter includes a pretax gain of $3.5
million; net income for the year includes a $5.3 million gain.
